Gold Shield Group TV Commercial, 'Type-2 Diabetes Medication Side Effects'

Published Dans

Gold Shield Group announces that various medications such as Invokana, Invokamet, Jardiance and Farxiga are linked to an increased risk of toe, leg and foot amputations. Type-2 Diabetics who suffered serious side effects after taking these medications are encouraged to call and file a claim.

Montre plus